Positive association between gastro-oesophageal reflux disease and irritable bowel syndrome in a Chinese populationCHEUNG, T. K; LAM, K. F; HU, W. H. C et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 9, pp 1099-1104, issn 0269-2813, 6 p.Article

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongXIA, B; XIA, H. H. X; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2005, Vol 22, Num 3, pp 243-249, issn 0269-2813, 7 p.Article

A prospective comparison of performance of biopsy forceps used in single passage with multiple bites during upper endoscopyCHU, K. M; YUEN, S. T; WONG, W. M et al.Endoscopy (Stuttgart). 2003, Vol 35, Num 4, pp 338-342, issn 0013-726X, 5 p.Article

Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese populationXIA, H. H.-X; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 521-526, issn 0269-2813Article

Sequential intravenous/oral antibiotic vs. continuous intravenous antibiotic in the treatment of pyogenic liver abscessNG, F. H; WONG, W. M; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 6, pp 1083-1090, issn 0269-2813Article

Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. CommentaryWINAWER, S. J; ZAUBER, A. G; HUI, W. M et al.Gut. 2001, Vol 48, Num 6, pp 753-754, issn 0017-5749, 6 p.Article

Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylationCHAN, A. O. O; PENG, J. Z; LAM, S. K et al.Gut. 2006, Vol 55, Num 4, pp 463-468, issn 0017-5749, 6 p.Article

Onset and disappearance of reflux symptoms in a Chinese population: a 1-year follow-up studyWONG, W. M; LAI, K. C; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 7, pp 803-812, issn 0269-2813, 10 p.Article

The role of cholecystectomy in reducing recurrent gallstone pancreatitisHUI, C. K; LAI, K. C; WONG, B. C. Y et al.Endoscopy (Stuttgart). 2004, Vol 36, Num 3, pp 206-211, issn 0013-726X, 6 p.Article

Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest painXIA, H. H. X; LAI, K. C; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 3, pp 369-377, issn 0269-2813, 9 p.Article

A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese populationWONG, B. C.-Y; WONG, W. M; LAI, K. C et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 9, pp 941-946, issn 0269-2813, 6 p.Article

Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users: a randomized trialLAI, K. C; LAM, S. K; CHU, K. M et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 8, pp 829-836, issn 0269-2813, 8 p.Article

Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based studyWONG, W. M; LAI, K. C; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 6, pp 595-604, issn 0269-2813, 10 p.Article

Coexistence between colorectal cancer/adenoma and coronary artery disease : results from 1382 patientsCHAN, A. O. O; LAM, K. F; TONG, T et al.Alimentary pharmacology & therapeutics. 2006, Vol 24, Num 3, pp 535-539, issn 0269-2813, 5 p.Article

Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agentsWANG, W. H; WONG, W. M; DAILIDIENE, D et al.Gut. 2003, Vol 52, Num 4, pp 490-495, issn 0017-5749, 6 p.Article

One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesWONG, W. M; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 4, pp 793-798, issn 0269-2813Article

Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest painWONG, W.-M; LAI, K. C; LAU, C. P et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 465-471, issn 0269-2813Article

Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese: prevalence and spectrum of the diseaseWONG, W.-M; LAM, S. K; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 12, pp 2037-2042, issn 0269-2813, 6 p.Article

Object assisted video coding for video conferencing systemLAI, K. C; WONG, S. C; LUN, Daniel et al.Lecture notes in computer science. 2002, pp 510-517, issn 0302-9743, isbn 3-540-00262-6, 8 p.Conference Paper

Pharmacological inhibition of protein kinase C activity could induce apoptosis in gastric cancer cells by differential regulation of apoptosis-related genesZHU, G. H; WONG, B. C. Y; EGGO, M. C et al.Digestive diseases and sciences. 1999, Vol 44, Num 10, pp 2020-2026, issn 0163-2116Article

Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer : a prospective long-term follow-up studyWONG, B. C. Y; LAM, S. K; LAI, K. C et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 3, pp 303-309, issn 0269-2813Article

Gastrointestinal: Villous adenoma of the esophagusWONG, W. M; SHEK, T. W.-H; CHAN, C.-K et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 10, issn 0815-9319, p. 1213Article

Hepatobiliary and pancreatic: Choledochoduodenal fistula secondary to duodenal ulcer diseaseWONG, W. M; HU, W. H. C; LAI, K. C et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 7, issn 0815-9319, p. 829Article

Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux diseaseWONG, W. M; LAI, K. C; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 4, pp 455-462, issn 0269-2813, 8 p.Article

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in chinese patients. CommentaryNYREN, O; WONG, W. M; HU, W. H. C et al.Gut. 2002, Vol 51, Num 4, pp 464-465, issn 0017-5749, 7 p.Article